Skip to Main Content

Paper Details

Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors.
Melanoma Research
1
2022
Author NameAffiliation
Meredith M ReganHarvard Medical School.
Meredith M ReganDana-Farber Cancer Institute
  • 1 - 2

Datasets

Release 1.2